<DOC>
	<DOCNO>NCT00627250</DOCNO>
	<brief_summary>The purpose study determine amantadine hydrochloride give 100 mg morning noon safe effective treatment mood behavior change ( i.e . irritability ) sustain traumatic brain injury .</brief_summary>
	<brief_title>Utility Amantadine Hydrochloride Treatment Post-traumatic Irritability</brief_title>
	<detailed_description>Amantadine hydrochloride drug use commonly clinical practice Carolinas Rehabilitation treatment mood behavior change follow traumatic brain injury . Clinical observation suggest use amantadine improves caregiver report `` irritability '' though study validate observation . This study investigate efficacy side effect profile amantadine hydrochloride give 2 dos 100 mg . Subjects screen regularly schedule clinic appointment presence irritability . If interested possible participation study , invite meet research coordinator obtain informed consent . If subject meet inclusion/exclusion requirement , leave clinic study medication begin take drug next day . There safety call day 3 5 dose may reduce per day . Follow-up assessment occurs day 14 ( phone ) day 28 ( clinic ) . At study completion , subject opportunity receive prescription amantadine part ongoing clinical care .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<criteria>Closed head injury ( defined brain injury impair brain function result externally inflict trauma without penetrate injury ) least 6 month prior enrollment . Age time enrollment : 16 65 inclusive ( i.e. , 16th birthday , day 66th birthday ) . Voluntary inform consent patient informant . Subject informant willing comply protocol , &amp; available schedule clinic visit . Neuropsychiatric Inventory ( NPI ) Irritability Domain score &gt; 2 . Medically neurologically stable month prior enrollment . If take antidepressant , anxiolytic , hypnotic , stimulant medication , change anticipate medication month prior enrollment . No change therapies medication plan 28day participation . No surgery plan 28day participation . Vision , hearing , speech , motor function , comprehension must sufficient compliance test procedure . Ability interact verbalize sufficient participate assessment . Informant ( family member close friend ) live participant daily interaction order observe occurrence irritability . Patients without reliable informant Penetrating head injury Injury &lt; 6 month prior enrollment Inability interact sufficient communication caregiver Acute rehabilitation record unavailable incomplete DSMIV diagnosis schizophrenia psychosis Diagnosis progressive additional neurologic disease ( , Alzheimer 's disease , parkinson 's disease , multiinfarct dementia , cerebrovascular disorder dementia , prior cerebrovascular accident , Huntington 's disease , olivopontocerebellar atrophy , multisystem atrophy , multiple sclerosis , ALS , CNS tumor , progressive supranuclear palsy ) . Diagnosis seizure month prior enrollment . Previous allergy adverse reaction study drug Ingestion amantadine hydrochloride month prior enrollment . Concomitant use neuroleptic agent phenelzine Creatinine clearance &lt; 60 Pregnancy ( BetaHCG perform female childbearing potential ) lactating female . Clinical sign active infection</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Irritability</keyword>
	<keyword>Aggression</keyword>
	<keyword>Brain Injury</keyword>
	<keyword>Amantadine</keyword>
	<keyword>Irritability Aggression Due Traumatic Brain Injury</keyword>
</DOC>